The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Changes in Gastrointestinal Hormones and Leptin after Roux-en-Y Gastric Bypass Procedure: A Review
Open accessAbstract
Roux-en-Y gastric bypass is a well-accepted tool for the treatment of obesity and, compared to conventional weight loss methods (eg, diet and exercise) and other weight loss surgeries (eg, gastric banding), it results in considerable weight loss that is maintained long term. Although successful, the mechanisms for weight loss are not completely understood and it is thought that gastrointestinal hormones play a role. Several gastrointestinal hormones have been identified for their effects on appetite, including glucagon-like peptide-1 (GLP-1), peptide tyrosine-tyrosine (PYY), leptin, and ghrelin. This review encompasses a literature search that included 45 primary articles and shows that there are alterations in GLP-1, PYY, leptin, and ghrelin postoperatively. GLP-1 and PYY concentrations were usually found to be higher, whereas ghrelin levels were typically lower post- Roux-en-Y gastric bypass than in individuals with obesity, those who were overweight or of normal weight, and in those who underwent procedures other than Roux-en-Y gastric bypass or who achieved weight loss by lifestyle modification. An understanding of how gastrointestinal hormones change after Roux-en-Y gastric bypass may help dietetics practitioners optimize nutrition care for this patient population. A review of the literature also highlighted some research gaps that should be taken into consideration when designing future studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biology of Incretins: GLP-1 and GIP
Baggio, L. L., & Drucker, D. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.054 · Cited by 3,639 · cited 7×
“Continued April2010 ● Journalofthe AM ERICAN DIETETIC ASSOCIATION 577 Hormones measured Limb length Study groups Time points Measurements Summary PYY, total and octanoylated ghrelin, leptin (57) 150 cm Group 1: RYGB (n"12, 12 F); Group 2: lean (n"8, 8 F); Group 3: BMI and age matched (to group 2) (n"12, 12 F) 35#5 mo…”
BackgroundResultInfluentialGut hormone PYY3-36 physiologically inhibits food intake
Batterham, R. L., Cowley, M. A., Small, C. J., Herzog, H., Cohen, M. A., Dakin, C. L., Wren, A. M., Brynes, A. E., Low, M. J., Ghatei, M. A., et al. (2002) · Nature · doi:10.1038/nature00887 · Cited by 2,351
Inhibition of Food Intake in Obese Subjects by Peptide YY 3–36
Batterham, R. L., Cohen, M. A., Ellis, S. M., Le Roux, C. W., Withers, D. J., Frost, G. S., Ghatei, M. A., & Bloom, S. R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030204 · Cited by 1,604
Gastrointestinal regulation of food intake
Cummings, D. E., & Overduin, J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30227 · Cited by 1,216 · cited 10×
“● Increasing gastrointestinal motility (11,35)”
BackgroundResultInfluentialRoux, C. W. L., Aylwin, S. J. B., Batterham, R. L., Borg, C. M., Coyle, F., Prasad, V., Shurey, S., Ghatei, M. A., Patel, A. G., & Bloom, S. R. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000183349.16877.84 · Cited by 985 · cited 6×
“Of the strongest study designs that included control groups and/or multiple sampling points (45,47,49,56-59) (Figure 2), the general consensus is that postprandial PYY levels are higher in post-RYGB subjects compared to lean (45,56-58), normal weight (59), overweight (49, 58), obese (45,47,56,57), and/or individuals u…”
BackgroundResultInfluentialGut hormones and the regulation of energy homeostasis
Murphy, K. G., & Bloom, S. R. (2006) · Nature · doi:10.1038/nature05484 · Cited by 778 · cited 10×
“There are two biological forms of GLP-1: GLP-17-36amide and GLP-17-37 with GLP-17-36amide being the most prevalent and active isoform (8).”
BackgroundResultInfluentialGut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass
le Roux, C. W., Welbourn, R., Werling, M., Osborne, A., Kokkinos, A., Laurenius, A., Lönroth, H., Fändriks, L., Ghatei, M. A., Bloom, S. R., et al. (2007) · Annals of Surgery · doi:10.1097/sla.0b013e3180caa3e3 · Cited by 741 · cited 13×
“Continued 578 April2010 Volum e 110 Num ber 4 Hormones measured Limb length Study groups Time points Measurements Summary Ghrelin, PYY, GLP-1 (49) Not reported Group 1: RYGB (n"8, 8 F); Group 2: GB (n"6, 6 F); Group 3: nonoperated weight matched to post-op RYGB and GB (n"8, 8 F) Post-op only (RYGB: 9 to 48 mo post-op;…”
BackgroundResultInfluentialLaferrère, B., Teixeira, J., McGinty, J., Tran, H., Egger, J. R., Colarusso, A., Kovack, B., Bawa, B., Koshy, N., Lee, H., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2851 · Cited by 682
Gastric Bypass for Obesity: Mechanisms of Weight Loss and Diabetes Resolution
Cummings, D. E., Overduin, J., & Foster-Schubert, K. E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0433 · Cited by 503
Consensus Conference Statement
Buchwald, H. (2005) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2005.04.002 · Cited by 489
Bariatric Surgery: A Review of Procedures and Outcomes
Elder, K. A., & Wolfe, B. M. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.057 · Cited by 470 · cited 9×
“Although these physiological modifications are thought to be a primary reason for the RYGB’s success, it is also important to consider the contribution of gastrointestinal hormones and neural pathways to the process (3).”
BackgroundResultInfluentialEnergy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men.
Näslund, E., Barkeling, B., King, N., Gutniak, M., Blundell, J., Holst, J., Rössner, S., & Hellström, P. (1999) · International Journal of Obesity · doi:10.1038/sj.ijo.0800818 · Cited by 468 · cited 5×
“Continued April2010 ● Journalofthe AM ERICAN DIETETIC ASSOCIATION 577 Hormones measured Limb length Study groups Time points Measurements Summary PYY, total and octanoylated ghrelin, leptin (57) 150 cm Group 1: RYGB (n"12, 12 F); Group 2: lean (n"8, 8 F); Group 3: BMI and age matched (to group 2) (n"12, 12 F) 35#5 mo…”
BackgroundResultInfluentialVerdich, C., Toubro, S., Buemann, B., Lysgård Madsen, J., Juul Holst, J., & Astrup, A. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801655 · Cited by 434
Goldfine, A. B., Mun, E. C., Devine, E., Bernier, R., Baz-Hecht, M., Jones, D. B., Schneider, B. E., Holst, J. J., & Patti, M. E. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0918 · Cited by 377 · cited 6×
“GLP-1, leptin (41) Not reported Group 1: RYGB with NG (n"12, 10 F); Group 2: RYGB without NG (n"9, 7 F); Group 3: overweight (n"10, 4 F); Group 4: morbidly obese (n"5, 5 F) Post-op only (3.”
BackgroundResultInfluentialKorner, J., Bessler, M., Inabnet, W., Taveras, C., & Holst, J. J. (2007) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2007.08.004 · Cited by 344 · cited 5×
“In the studies that utilized a control group (41-49) and/or sampled at multiple time points (6,41-47,50) (Figure 2), the data concerning GLP-1 after RYGB is consistent.”
ResultInfluentialGlucagon-like peptide 1(GLP-1) in biology and pathology
Meier, J. J., & Nauck, M. A. (2005) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.538 · Cited by 288 · cited 6×
“Continued April2010 ● Journalofthe AM ERICAN DIETETIC ASSOCIATION 577 Hormones measured Limb length Study groups Time points Measurements Summary PYY, total and octanoylated ghrelin, leptin (57) 150 cm Group 1: RYGB (n"12, 12 F); Group 2: lean (n"8, 8 F); Group 3: BMI and age matched (to group 2) (n"12, 12 F) 35#5 mo…”
BackgroundResultInfluentialMeier, C. A., Bobbioni, E., Gabay, C., Assimacopoulos-Jeannet, F., Golay, A., & Dayer, J.-M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8351 · Cited by 287 · cited 3×
“More than half of the reviewed studies that measured leptin were of strong design (37,41,57,58,61-70) (Figure 2); however, some studies only compared pre-RYGB leptin levels to the post-RYGB state and did not make comparisons to the control group (eg, obese, lean) that was included in the study design (63,64,66).”
MethodResultEffect of Fasting, Refeeding, and Dietary Fat Restriction on Plasma Leptin Levels
Weigle, D. S. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.2.561 · Cited by 287
Differential Effects of Gastric Bypass and Banding on Circulating Gut Hormone and Leptin Levels
Korner, J., Inabnet, W., Conwell, I. M., Taveras, C., Daud, A., Olivero‐Rivera, L., Restuccia, N. L., & Bessler, M. (2006) · Obesity · doi:10.1038/oby.2006.179 · Cited by 240 · cited 7×
“Of the strongest study designs that included control groups and/or multiple sampling points (45,47,49,56-59) (Figure 2), the general consensus is that postprandial PYY levels are higher in post-RYGB subjects compared to lean (45,56-58), normal weight (59), overweight (49, 58), obese (45,47,56,57), and/or individuals u…”
BackgroundResultInfluentialEffects of gastric bypass and gastric banding on glucose kinetics and gut hormone release
Rodieux, F., Giusti, V., D'Alessio, D. A., Suter, M., & Tappy, L. (2008) · Obesity · doi:10.1038/oby.2007.83 · Cited by 216 · cited 8×
“Of the strongest study designs that included control groups and/or multiple sampling points (45,47,49,56-59) (Figure 2), the general consensus is that postprandial PYY levels are higher in post-RYGB subjects compared to lean (45,56-58), normal weight (59), overweight (49, 58), obese (45,47,56,57), and/or individuals u…”
BackgroundResultInfluential
Cited by
Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association
Bays, H. E., Toth, P. P., Kris-Etherton, P. M., Abate, N., Aronne, L. J., Brown, W. V., Gonzalez-Campoy, J. M., Jones, S. R., Kumar, R., La Forge, R., et al. (2013) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2013.04.001 · Cited by 521
Dickson, S. L., Shirazi, R. H., Hansson, C., Bergquist, F., Nissbrandt, H., & Skibicka, K. P. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.6326-11.2012 · Cited by 414
Janssen, P., Vanden Berghe, P., Verschueren, S., Lehmann, A., Depoortere, I., & Tack, J. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04609.x · Cited by 348
Jacobsen, S. H., Olesen, S. C., Dirksen, C., Jørgensen, N. B., Bojsen-Møller, K. N., Kielgast, U., Worm, D., Almdal, T., Naver, L. S., Hvolris, L. E., et al. (2012) · Obesity Surgery · doi:10.1007/s11695-012-0621-4 · Cited by 342
Jørgensen, N. B., Jacobsen, S. H., Dirksen, C., Bojsen-Møller, K. N., Naver, L., Hvolris, L., Clausen, T. R., Wulff, B. S., Worm, D., Lindqvist Hansen, D., et al. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00073.2012 · Cited by 313
“The greatly increased GLP-1 secretion observed in subjects with both T2D and NGT very early after RYGB extends earlier reports of increased GLP-1 secretion months to years after RYGB (2, 18, 20, 22, 43, 48).”
Background
Metadata
- Authors
- Beckman, L. M., Beckman, T. R., & Earthman, C. P.
- Venue
- Journal of the American Dietetic Association
- Publisher
- Elsevier BV
- Published
- 2010-04
- Volume
- 110
- Issue
- 4
- Pages
- 571-584
- ISSN
- 0002-8223 (ISSN-L)
- OpenAlex
- W2093139970
- Cited by
- 195
- References
- 20
- FWCI
- 26.08
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.